Duan Quanlu, Chen Chen, Yang Lei, Li Ni, Gong Wei, Li Sheng, Wang Dao Wen
Department of Internal Medicine and the Institute of Hypertension, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, 430030, Wuhan, People's Republic of China.
J Transl Med. 2015 Nov 16;13:363. doi: 10.1186/s12967-015-0725-4.
XBP1 is a key transcription factor of the unfolded protein response in mammalian cells, which is involved in several cardiovascular pathological progression including cardiac hypertrophy and myocardial infarction, but its expression trend, function and upstream regulate mechanism in the development of heart failure are unclear. In the present study, therefore, the potential role of miRNAs in the regulation of XBP1 expression in heart failure was examined.
First, western blots showed that cardiac expression of ER stress marker XBP1 were induced in the early adaptive phase, but decreased in the maladaptive phase in hypertrophic and failing heart, while there was no obvious change of upstream ATF6 and IRE1 activity in this progression. Interestingly, we further found that XBP1 and its downstream target VEGF were attenuated by miR-30* and miR-214 in cardiomyocyte. Moreover, we found that miR-30* was significantly reduced in the early phase of cardiac hypertrophic animal model and in human failing hearts, while both miR-214 and miR-30* were increased in the maladaptive diseased heart, thereby contribute to impairment of cardiac XBP1 and VEGF expression.
These results provide the first clear link between miRNAs and direct regulation of XBP1 in heart failure and reveal that miR-214 and miR-30* synergistically regulates cardiac VEGF expression and angiogenesis by targeting XBP1 in the progression from adaptive hypertrophy to heart failure.
XBP1是哺乳动物细胞中未折叠蛋白反应的关键转录因子,参与包括心脏肥大和心肌梗死在内的多种心血管病理进程,但其在心力衰竭发生发展过程中的表达趋势、功能及上游调控机制尚不清楚。因此,在本研究中,我们检测了微小RNA(miRNA)在心力衰竭中对XBP1表达调控的潜在作用。
首先,蛋白质免疫印迹法显示,内质网应激标志物XBP1在肥大和衰竭心脏的早期适应性阶段心脏表达升高,但在失代偿阶段降低,而在此进程中上游激活转录因子6(ATF6)和肌醇需求酶1(IRE1)活性无明显变化。有趣的是,我们进一步发现,在心肌细胞中,miR-30和miR-214可使XBP1及其下游靶点血管内皮生长因子(VEGF)表达减弱。此外,我们发现,在心脏肥大动物模型早期阶段及人类衰竭心脏中,miR-30显著降低,而在失代偿性病变心脏中miR-214和miR-30*均升高,从而导致心脏XBP1和VEGF表达受损。
这些结果首次明确了miRNA与心力衰竭中XBP1直接调控之间的联系,并揭示在从适应性肥大到心力衰竭的进程中,miR-214和miR-30*通过靶向XBP1协同调节心脏VEGF表达及血管生成。